8-Prenylnaringenin 98% Powder
1 Inquiries
53846-50-7
Pharmaceutical Grade
98%
Asia
25kg/drum
2023-11-23
Nootropics,Sarms,Peptides,API,Intermediates
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
(-)-8-Prenylnaringenin
Other Name:4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-buten-1-yl)-,(2S)-;4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-butenyl)-,(S)-;4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-butenyl)-,(2S)-;(2S)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one;Flavaprenin;Sophoraflavanone B;8-C-Prenylnaringenin;8-Prenylnaringenin;(-)-8-Prenylnaringenin;8-Prenylnarangenin
CAS No.:53846-50-7
Molecular Formula:C20H20O5
InChIKeys:InChIKey=LPEPZZAVFJPLNZ-SFHVURJKSA-N
Molecular Weight:340.375
Exact Mass:340.37
UNII:5L872SZR8X
DSSTox ID:DTXSID60333083
Categories:
Characteristics-
PSA:
87
XLogP3:5.28
Density:1.3±0.1 g/cm3
Boiling Point:597.6±50.0 °C at 760 mmHg
Flash Point:216.4±23.6 °C
Refractive Index:1.642
Storage Conditions:2-8°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Nootropics,Sarms,Peptides,API,Intermediates
-
Location:
Kemp House, 160 City Road London, EC1V 2NX
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
2
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2021
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
Poland
8-PRENYLNARINGENIN
0.005 G Oct 23, 2023 Post an enquiry for this product